Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Cystic Fibrosis - Pipeline Assessment and Market Forecasts to' returned 14 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom U.S. Inherited Disease Molecular Diagnostics Markets   Frost & Sullivan, July 2010, Pages: 60 (U.S.), 2006-2016 - Inherited Disease Molecular Diagnostics Market: Revenue Forecast by Cystic Fibrosis Tests (U.S.), 2006-2016 - Inherited Disease Molecular Diagnostics Market: Revenue Forecast Delivering Drugs by Inhalation   Greystone Associates, Dec 2010 illnesses and conditions are treated. Highlights - Analyzes and evaluates inhaled drugs currently in development and assesses the market potential for existing and probable future products - Examines Dry Powder Inhalation: Technology, Devices, Markets and Opportunities   Greystone Associates, Jan 2012 Factors Systemic Drug Delivery Bioterror Diabetes Hereditary Diseases Cystic Fibrosis Infectious Diseases Osteoporosis Neurology Pain Management Market Factors Device Design Regulatory Issues Patient Global Genetic Testing Market Analysis   RNCOS E-Services Private Limited, Jan 2012, Pages: 65 's Disease 5.2 Cystic Fibrosis 5.3 Cancer 6. Country-Level Analysis 6.1 US 6.2 Europe 6.3 Korea 7. Industry Developments 7.1 Recent Product Launches 7.2 Recent Strategic Acquisitions & Agreements 8 Molecular Diagnostics - Technologies, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 1037 genetic diagnosis Conditions detected by preimplantation genetic diagnosis The future of preimplantation genetic diagnosis Companies involved in prenatal/preimplantation diagnosis Cystic fibrosis Telemonitoring: Challenges & Opportunities   Espicom Business Intelligence Ltd, Nov 2011, Pages: 152 Medical's Onyx II Model 9560 Applied Nanodetectors' Sensor Array Platform Aipermon's Telemonitoring Solution for Cystic Fibrosis and COPD Deep Breeze's Breeze@home HYPERTENSION The Role The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine   Business Insights, June 2010, Pages: 191 coverage Chapter 3 Market developments Summary Extracting microRNAs from tissue Cystic fibrosis genetic screening PET scanning Expanded medicare coverage Ionian Technologies-Roche collaboration Molecular Diagnostics Markets   TriMark Publications, July 2011, Pages: 335 Diagnostics Testing 4.6.6.1 Cystic Fibrosis 4.6.6.2 Viral Load Testing 4.6.6.3 NMP22 4.6.6.4 Trends in Reimbursement Practice 4.6.6.5 Medicare Reimbursement Threats 4.7 Patent Protection and Intellectual Molecular Diagnostics: A Primer on an Emerging Sector   Datamonitor, Nov 2008, Pages: 147 American Diagnosticas D-dimer ActiScreen XI-FDF assay 135 Various genes 136 Clinical datas Famillion test 136 Respiratory 137 CFTR 137 Celeras Cystic fibrosis genotypic assay 137 Third Waves InplexCF 138 The 2011 Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers   Venture Planning Group, Feb 2010, Pages: 1050 Pharmacogenomic Testing h. Major Diseases * Achondroplasia * Autosomal Dominant Polycystic Kidney Disease * Cancer * Cosmetogenomics * Cystic Fibrosis * Down's Syndrome * Duchenne and Becker Muscular Dystrophy Global Nucleic Acid Testing Market - New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers   Venture Planning Group, June 2011, Pages: 1050 Polycystic Kidney Disease * Cancer * Cosmetogenomics * Cystic Fibrosis * Down's Syndrome * Duchenne and Becker Muscular Dystrophy * Factor V (Leiden) * Factor IX Deficiency * Fragile X Syndrome * Heart Disease The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics   Business Insights, May 2005 ) Key RNAi players Conclusions Respiratory Respiratory Syncytial Virus (RSV) Key RNAi players Asthma Key RNAi players Cystic fibrosis Key RNAi players Conclusions Neurological diseases Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009   Life Science Intelligence, Inc., Dec 2009, Pages: 1763 disc replacement that can be converted to fusion - Therapy delivery platform for the upper airway with applications to initially target chronic sinusitis, nasal allergies, cystic fibrosis, and CPAP The Molecular Diagnostics Market DNA Probes And Biochips: A 7-Country Market Survey   Venture Planning Group, Sep 2005, Pages: 1050 Testing h. Major Diseases - Achondroplasia - Autosomal Dominant Polycystic Kidney Disease - Cancer - Cosmetogenomics - Cystic Fibrosis - Down's Syndrome - Duchenne and Becker Muscular Dystrophy - Factor V Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network